A detailed history of Woodline Partners LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,028,287 shares of FOLD stock, worth $10.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,028,287
Holding current value
$10.1 Million
% of portfolio
0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.55 - $12.09 $9.82 Million - $12.4 Million
1,028,287 New
1,028,287 $11 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $11.12 $5.38 Million - $9.61 Million
-864,282 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.89 - $12.48 $6.82 Million - $10.8 Million
864,282 New
864,282 $8.19 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.